BMAL1 and hepatocellular carcinoma: Furthermore, BMAL1 could partially reverse the reduction of GSH (Fig. 3N) and the upregulation of ROS (Fig. 3O) and MDA (Fig. 3P and Fig. S3L) in DCAF7-knockdown HCC cells.